Your browser doesn't support javascript.
loading
Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events.
Les, Iñigo; Martínez, Mireia; Pérez-Francisco, Inés; Cabero, María; Teijeira, Lucía; Arrazubi, Virginia; Torrego, Nuria; Campillo-Calatayud, Ana; Elejalde, Iñaki; Kochan, Grazyna; Escors, David.
Afiliación
  • Les I; Internal Medicine Department, Navarre University Hospital, 31008 Pamplona, Spain.
  • Martínez M; Autoimmune Diseases Unit, Internal Medicine Department, Navarre University Hospital, 31008 Pamplona, Spain.
  • Pérez-Francisco I; Inflammatory and Immune-Mediated Diseases Group, Instituto de Investigación Sanitaria de Navarra (IdISNA), Navarrabiomed-Public University of Navarre, 31008 Pamplona, Spain.
  • Cabero M; Osakidetza Basque Health Service, Department of Medical Oncology, Araba University Hospital, 01009 Vitoria-Gasteiz, Spain.
  • Teijeira L; Lung Cancer Research Group, Bioaraba Health Research Institute, 01006 Vitoria-Gasteiz, Spain.
  • Arrazubi V; Breast Cancer Research Group, Bioaraba Health Research Institute, 01006 Vitoria-Gasteiz, Spain.
  • Torrego N; Clinical Trials Platform, Bioaraba Health Research Institute, 01006 Vitoria-Gasteiz, Spain.
  • Campillo-Calatayud A; Medical Oncology Department, Navarre University Hospital, 31008 Pamplona, Spain.
  • Elejalde I; Medical Oncology Department, Navarre University Hospital, 31008 Pamplona, Spain.
  • Kochan G; Osakidetza Basque Health Service, Department of Medical Oncology, Araba University Hospital, 01009 Vitoria-Gasteiz, Spain.
  • Escors D; Lung Cancer Research Group, Bioaraba Health Research Institute, 01006 Vitoria-Gasteiz, Spain.
Cancers (Basel) ; 15(5)2023 Mar 06.
Article en En | MEDLINE | ID: mdl-36900420

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: España
...